On November 3, 2025, Chief Technical Officer Joseph Shulman of Rhythm Pharmaceuticals ( RYTM +1.84%) exercised 9,748 options ...
Moderated by pharmaphorum’s web editor Nicole Raleigh, the session featured three expert panellists: Mo Rice, Vice President ...
Fintel reports that on November 18, 2025, B of A Securities maintained coverage of Jazz Pharmaceuticals (NasdaqGS:JAZZ) with ...
Achieving proper drug dosages , particularly for pediatric patients, has been a pivotal point of research in pharmacology.
You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
The full manuscript, titled “Enozertinib is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-small Cell Lung Cancer with EGFR Exon 20 and Atypical Mutations,” is available online at Cancer ...
Joint promotion of the Parsortix platform and QIAGEN’s molecular technologiesOpportunity for the development of a companion diagnostic assayGuildford, UK, – 18 November 2025 – CELLBXHEALTH plc (AIM: ...
West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST ...
On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback